News Releases Year None202220212020201920182017 NuCana Announces Presentation on NUC-7738 at the European Hematology Association (EHA) 2022 Hybrid Congress Jun 10, 2022 NuCana Announces Receipt of NASDAQ Notice Jun 03, 2022 NuCana Reports First Quarter 2022 Financial Results and Provides Business Update Jun 02, 2022 NuCana to Participate in the 2022 Jefferies Healthcare Conference Jun 01, 2022 NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update Apr 27, 2022 NuCana Announces Upcoming Presentations on NUC-3373 at the American Association for Cancer Research (AACR) Annual Meeting 2022 Mar 08, 2022 NuCana Announces Update for Phase 3 Biliary Tract Cancer Study Mar 02, 2022 NuCana to Participate in Two Upcoming Investor Conferences Feb 28, 2022 NuCana Announces Enrollment of Required Number of Patients to Conduct Second Interim Analysis in the Phase III Biliary Tract Cancer Study Feb 22, 2022 NuCana Reports Third Quarter 2021 Financial Results and Provides Business Update Nov 18, 2021 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
NuCana Announces Presentation on NUC-7738 at the European Hematology Association (EHA) 2022 Hybrid Congress Jun 10, 2022
NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update Apr 27, 2022
NuCana Announces Upcoming Presentations on NUC-3373 at the American Association for Cancer Research (AACR) Annual Meeting 2022 Mar 08, 2022
NuCana Announces Enrollment of Required Number of Patients to Conduct Second Interim Analysis in the Phase III Biliary Tract Cancer Study Feb 22, 2022